Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Malignant hyperthermia]

A Urwyler1, E Hartung

  • 1Departement Anästhesie, Universitätsklinik Basel.

Der Anaesthesist
|August 1, 1994
PubMed
Summary
This summary is machine-generated.

Malignant hyperthermia (MH) is a rare, life-threatening pharmacogenetic disorder. Early diagnosis and treatment with dantrolene are crucial for managing MH crises triggered by anesthesia.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Relationship between dairy cows' hind leg activity and vacuum records during milking.

Animal : an international journal of animal bioscience·2021
Same author

Evaluation of three methods to assess the degree of milk-out in dairy cows.

Animal : an international journal of animal bioscience·2019
Same author

Suitability of feeding and chewing time for estimation of feed intake in dairy cows.

Animal : an international journal of animal bioscience·2015
Same author

European Malignant Hyperthermia Group guidelines for investigation of malignant hyperthermia susceptibility.

British journal of anaesthesia·2015
Same author

Feeding characteristics and rumination time of dairy cows around estrus.

Journal of dairy science·2014
Same author

Pressure load on specific body areas of gestating sows lying on rubber mats with different softness.

Journal of animal science·2014
Same journal

[Promoting young academics in anesthesiology: factors for an attractive internship].

Der Anaesthesist·2022
Same journal

[Respiratory support in COVID-19: all in due time!]

Der Anaesthesist·2022
Same journal

[Noninvasive respiratory support and invasive ventilation in COVID‑19 : Where do we stand today?]

Der Anaesthesist·2022
Same journal

[Management of acutely decompensated liver cirrhosis in emergency and critical care medicine].

Der Anaesthesist·2022
Same journal

[Anesthesia in patients with acute porphyria].

Der Anaesthesist·2022
Same journal

[Quality and safe anesthesia for all children : That is their right!]

Der Anaesthesist·2022
See all related articles

Area of Science:

  • Pharmacogenetics
  • Anesthesiology
  • Molecular Biology

Context:

  • Malignant hyperthermia (MH) is a rare, life-threatening pharmacogenetic disease affecting approximately 1:10,000 individuals.
  • MH susceptibility is triggered by volatile anesthetics and depolarizing muscle relaxants, leading to abnormal intracellular calcium levels in skeletal muscle.
  • Clinical manifestations range from mild symptoms to severe MH crises.

Purpose:

  • To summarize the understanding of Malignant Hyperthermia (MH), its triggers, clinical presentation, and current diagnostic and therapeutic strategies.
  • To highlight the genetic basis of MH, including the role of the ryanodine receptor gene.
  • To underscore the importance of early diagnosis and prompt management in MH cases.

Summary:

  • MH is a pharmacogenetic disorder with an incidence of 1:10,000, triggered by anesthetics causing increased intracellular calcium in muscle.

Related Experiment Videos

  • Effective MH therapy involves early diagnosis, monitoring (ECG, capnography), stopping triggers, and dantrolene treatment.
  • Genetic alterations in the ryanodine receptor gene are implicated, and MH is increasingly viewed as a heterogenetic disease, diagnosed via halothane-caffeine contracture test.

    • Impact:

    • Improved understanding of MH pathophysiology and genetic basis.
    • Enhanced clinical management strategies for MH patients, emphasizing early detection and intervention.
    • Potential for developing more targeted diagnostic and therapeutic approaches for MH susceptibility.